Advisory Board

 

The agenda is being shaped by an industry advisory board, with members including:

 

Christian Klein, Head of Oncology Programmes, Roche Pharmaceutical Research and Early Development
Christian Klein

Head of Oncology Programmes
Roche Pharmaceutical Research and Early Development

Hans-Peter Gerber, CSO and President, Maverick Therapeutics
Hans-Peter Gerber
CSO and President
Maverick Therapeutics

 

Ahuva Nissim, Reader, Antibody and Therapeutic Engineering, Queen Mary University of London
Ahuva Nissim
Reader, Antibody and Therapeutic Engineering
Queen Mary University of London

Alain Beck, Senior Director, NBEs Analytical Chemistry, Pierre Fabre, Associate Editor, mAbs
Alain Beck
Senior Director, NBEs Analytical Chemistry, Pierre Fabre ; Associate Editor, mAbs

 

Ulrich Brinkmann, Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Centre Munich
Ulrich Brinkmann
Scientific Director, Roche Pharma Research & Early Development
Roche Innovation Centre Munich

Ezio Bonvini, SVP & CSO, Research, Macrogenics
Ezio Bonvini
SVP & CSO, Research
Macrogenics 

 
 

John Delaney, Executive Director, Amgen Biologics Discovery
John Delaney
Executive Director
Amgen Biologics Discovery 

Christian Rommel, Global Head of Oncology Discovery, Roche
Christian Rommel
Global Head of Oncology Discovery
Roche

 

Janice Reichert, Executive Director, The Antibody Society; Editor-in-Chief, mABs
Janice Reichert
Executive Director, The Antibody Society ; Editor-in-Chief, mABs

Michael DeRidder, Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy, Neuroscience, and ADD, GSK
Michael DeRidder
Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy, Neuroscience, and ADD
GSK

 
 

Peter Senter, VP, Distinguished Research Fellow, Seattle Genetics
Peter Senter
VP, Distinguished Research Fellow
Seattle Genetics

 

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.

 

Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October

Sign Up for Event Updates